Palantir Technologies delivered outstanding Q3 2025 results, with revenue up 63% and EPS beating estimates by over 25%. Read ...

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Who is the Most Famous Child Prodigy? Discover the inspiring stories of 9 famous child prodigies who changed the world with their extraordinary talents and achievements from a young age.